OTC Consumer Health Market Growth 2025 BURLINGAME, CA, UNITED STATES, March 11, 2025 /EINPresswire / --The Global OTC Consumer Health ...

A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache segment in India.On 11 November 2014, Sanofi India ...

These products are sold principally in the prescription market, but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas: Sanofi’s CEO ...

Czech Republic-based Zentiva Pharma, a generics and over-the-counter medicines company that is wholly-owned by private equity ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...

Pertussis Treatment Market Pertussis Medications and Vaccinations Leading Therapeutic Approaches Driving Stance of Companies in the Market: ...

Over the past decade researchers have uncovered significant links between many of our most commonly used drugs - and patients taking them suffering depression.

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

1 Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration ... including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version of ...